Waters Investor

Waters Division creates business advantages for laboratory-dependent organizations by delivering ultra-performance liquid chromatography (UPLC), high-performance liquid chromatography (HPLC), chromatography columns and chemistry products, mass spectrometry systems, laboratory informatics solutions, and comprehensive service programs to enable significant advancement in healthcare delivery, environmental management, food safety, and water quality.


Invests into

Technology: Predictive Toxicology and ADMET Modeling
Industry: BioPharma AI
Founded Date: 1905-01-01
Investor Type: Venture Funds
Headquarters: Milford,Massachusetts,United States,North America
Funding Status: public